TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Foster City, California, focused on developing innovative small-molecule therapies aimed at treating nonalcoholic steatohepatitis (NASH) and other serious chronic liver diseases. With a robust pipeline of both single-agent and combination therapy candidates, Terns is at the forefront of addressing unmet medical needs in hepatology. The company’s commitment to advancing its clinical programs positions it as a key player in the biopharmaceutical landscape, potentially offering significant value to investors as it works towards bringing its therapies to market.